| Affiliation: | 1. Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands;2. Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, United States;3. Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, United States;4. University of Chicago Medicine, Chicago, Illinois, United States;5. Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Waltham, Boston, Massachusetts, United States;6. Diabetes Trials Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK;7. Correspondence |
